Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPERE.L Regulatory News (PERE)

  • There is currently no data for PERE

Variation to a Loan Facility

18 Jan 2021 14:37

RNS Number : 0650M
Pembridge Resources plc
18 January 2021
 

 

18 January 2021

Variation to a Loan Facility

London, United Kingdom - Pembridge Resources plc (LSE: PERE) ("Pembridge" or the "Company") announces a change to its loan facility.

As previously noted in the RNS on 14 February 2020, the Company's Chairman and CEO, Gati Al-Jebouri, committed to providing a facility to the Company of up to £2,000,000 through a convertible loan which was referred to as Facility C which incurred interest of 10% per annum and is repayable on 31 December 2022.

The Company has since drawn down £1,730,000 from Facility C. Also, since commencing Facility C, Mr. Al-Jebouri has participated in two separate equity capital raises and contributed £123,792 in May 2020 and £120,000 in January 2021.

Following the closing of the recent equity raise, the Company is now fully funded for the next 2 years, therefore, it has agreed that it no longer needs to draw down any further on Facility C. The Company and Mr. Al-Jebouri have duly agreed to vary Facility C to a maximum draw down of £1,730,000 being the current outstanding balance thus no further funds shall be drawn down.

 

ENDS

 

NOTES TO EDITORS

About Pembridge Resources plc

Pembridge is a mining company that is listed on the standard segment of the Official List of the FCA and trading on the main market for listed securities of London Stock Exchange plc. Pembridge has an investment in Minto Explorations Ltd, a British Columbia incorporated business operating the Minto mine in Yukon, Canada.

Enquiries:

 

Pembridge Resources plc: +44 (0)20 7917 2968

Gati Al-Jebouri, Chief Executive Officer and Chairman of the Board

David James, Chief Financial Officer

 

Brandon Hill Capital - United Kingdom: +44 (0)20 3463 5016

Jonathan Evans

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZGMMDRKGMZM
Date   Source Headline
15th May 20174:41 pmRNSPosting of Notice of AGM
12th May 20177:00 amRNSResults for the Year Ended 31 December 2016
3rd May 20175:06 pmRNSUpdate on AIM Rule 15 status
18th Apr 20177:00 amRNSSenior Management Appointment
11th Apr 20178:28 amRNSTR-1: Notification of major interest in shares
10th Apr 20177:00 amRNSAppointment of Shard Capital Partners as Broker
10th Apr 20177:00 amRNSSenior Management Appointment
7th Apr 201711:20 amRNSChange of Name, Registered Address and Update
28th Mar 20175:59 pmRNSTR-1: Notification of Major Interest in Shares
23rd Mar 20179:34 amRNSChange of Name
16th Mar 20173:51 pmRNSHolding in Company
9th Mar 20177:00 amRNSSenior Management Appointment
2nd Mar 20178:26 amRNSAppointment of Frank McAllister to Advisory Board
2nd Mar 20177:00 amRNSChange of Name and Notice of GM
28th Feb 20178:40 amRNSAppointment of Guy Le Bel to Advisory Board
20th Feb 20178:11 amRNSNotifiable Holding
17th Feb 20171:36 pmRNSBoard Changes
8th Feb 201710:00 amRNSInvestment Agreement - USA Lithium
1st Feb 20177:00 amRNSInvestment Agreement Botswana
26th Jan 20178:04 amRNSChange of Adviser
11th Jan 20178:17 amRNSCompletion of In-Specie Distribution Process
30th Dec 20168:53 amRNSStrategic and Operational Update
29th Dec 201610:00 amRNSChange of Registered Office
19th Dec 201610:06 amRNSDirector Share Purchase
14th Dec 20161:11 pmRNSResult of GM
25th Nov 20169:14 amRNSNotice of GM
21st Nov 201612:38 pmRNSFurther re Capital Reorganisation
21st Nov 20169:22 amRNSCapital Reorganisation
16th Nov 201610:18 amRNSShare Price Movement
11th Aug 201612:34 pmRNSShare Price Movement
27th Jul 201611:12 amRNSHalf-year Report
7th Jul 20163:16 pmRNSResult of AGM
14th Jun 20162:57 pmRNSNotice of AGM
17th May 201611:03 amRNSAnnual Financial Report
9th May 20167:00 amRNSFinal Results
27th Apr 201611:20 amRNSChange of Address
16th Nov 201511:15 amRNSLoan from HK ECE and Directorate Change
3rd Sep 20157:00 amRNSInterim Results
9th Jun 20151:00 pmRNSResult of AGM
6th May 20159:34 amRNSNotice of AGM and Posting of Annual Report
13th Apr 20157:00 amRNSChange of Address
4th Mar 20157:00 amRNSFinal Results
10th Sep 20147:00 amRNSDirectorate Changes
10th Sep 20147:00 amRNSInterim Results
17th Jul 20146:00 pmRNSDirectorate Change
10th Jun 201412:53 pmRNSResult of AGM
3rd Jun 20147:00 amRNSNotice of AGM and Posting of Annual Report
27th May 20147:00 amRNSBerg Aukas Pre Feasibility Study Results
14th Mar 20147:00 amRNSFinal Results
29th Jan 20147:00 amRNSUpdate on Feasibility Study

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.